Cancer Terms

c-Met Inhibitor JNJ-38877605

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Enzyme Inhibitor -> Protein Kinase Inhibitor -> Tyrosine Kinase Inhibitor -> c-Met Inhibitor JNJ-38877605

c-Met Inhibitor JNJ-38877605 Definition

An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity. c-Met inhibitor JNJ-38877605 selectively inhibits c-Met (mesenchymal-epithelial transition), a receptor tyrosine kinase (RTK) involved in cancer cell survival and invasiveness, and tumor angiogenesis. c-Met is also known as hepatocyte growth factor receptor (HGFR).

c-Met Inhibitor JNJ-38877605 Synonyms

c-Met Inhibitor JNJ-38877605, JNJ-38877605

Terms in c-Met Inhibitor JNJ-38877605 category



Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods

No reproduction or republication permitted.